• 1
    Brown MA. Genetics of ankylosing spondylitis. Curr Opin Rheumatol 2010; 22: 12632.
  • 2
    Gagliardi MC, Teloni R, Mariotti S, Bromuro C, Chiani P, Romagnoli G, et al. Endogenous PGE2 promotes the induction of human Th17 responses by fungal β-glucan. J Leukoc Biol 2010; 88: 94754.
  • 3
    Zeng L, Lindstrom MJ, Smith JA. Ankylosing spondylitis macrophage production of higher levels of interleukin-23 in response to lipopolysaccharide without induction of a significant unfolded protein response. Arthritis Rheum 2011; 63: 380717.
  • 4
    Prevosto C, Goodall JC, Gaston JS. IL-12 and IL-23 secretion by dendritic cells in spondyloarthropathy [abstract]. Ann Rheum Dis 2009; 68 Suppl I: A39.
  • 5
    Colbert RA, DeLay ML, Klenk EI, Layh-Schmitt G. From HLA-B27 to spondyloarthritis: a journey through the ER. Immunol Rev 2010; 233: 181202.
  • 6
    Goodall JC, Wu C, Zhang Y, McNeill L, Ellis L, Saudek V, et al. Endoplasmic reticulum stress-induced transcription factor, CHOP, is crucial for dendritic cell IL-23 expression. Proc Natl Acad Sci U S A 2010; 107: 17698703.
  • 7
    Ghoreschi K, Laurence A, Yang XP, Tato CM, McGeachy MJ, Konkel JE, et al. Generation of pathogenic TH17 cells in the absence of TGF-β signalling. Nature 2010; 467: 96771.
  • 8
    Baeten D, Sieper J, Emery P, Braun J, van der Heijde D, McInnes I, et al. The anti-IL17A monoclonal antibody secukinumab (AIN457) showed good safety and efficacy in the treatment of active ankylosing spondylitis [abstract]. Arthritis Rheum 2010; 62 Suppl: S38401.
  • 9
    Sarin R, Wu X, Abraham C. Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses. Proc Natl Acad Sci U S A 2011; 108: 95605.
  • 10
    Shen H, Goodall JC, Gaston JS. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum 2009; 60: 164756.
  • 11
    Bowness P, Ridley A, Shaw J, Chan AT, Wong-Baeza I, Fleming M, et al. Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis. J Immunol 2011; 186: 267280.
  • 12
    Appel H, Maier R, Wu P, Scheer R, Hempfing A, Kayser R, et al. Analysis of interleukin-17+ cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17 mediated adaptive immune response. Arthritis Res Ther 2011; 13: R95.
  • 13
    Yeremenko N, Noordenbos T, Gofita I, Tak PP, Canete JD, Baeten D. Mast cells contribute to synovial inflammation in non-psoriatic and psoriatic spondyloarthritis [abstract]. Ann Rheum Dis 2011; 70 Suppl II: A545.
  • 14
    Geremia A, Arancibia-Carcamo CV, Fleming MP, Rust N, Singh B, Mortensen NJ, et al. IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med 2011; 208: 112733.
  • 15
    Pickert G, Neufert C, Leppkes M, Zheng Y, Wittkopf N, Warntjen M, et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med 2009; 206: 146572.
  • 16
    Nograles KE, Brasington RD, Bowcock AM. New insights into the pathogenesis and genetics of psoriatic arthritis. Nat Clin Pract Rheumatol 2009; 5: 8391.